Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 12, 2026
Cycle Pharmaceuticals has selected Forma Life Sciences to establish U.S. commercial manufacturing supply for Cavhanza, an FDA-approved orally disintegrating nilotinib tablet for adults with Philadelphia chromosome-positive chronic myeloid leukemia.
read more
Wednesday, August 12, 2026
Aurisco Pharmaceutical said its Yangzhou, China manufacturing site has passed an FDA pre-approval inspection for inclisiran sodium, describing the facility as the first generic oligonucleotide active pharmaceutical ingredient manufacturer in the ...
read more
Altasciences is expanding its North American bioanalytical laboratory network through new capacity in Greater Montréal and a purpose-built laboratory in Harleysville, Pennsylvania, as the contract research organization responds to demand for late-...
read more
This $30 million investment will add advanced analytical development and process R&D capabilities, alongside upgrades to multiple production plants, reinforcing Cambrex's commitment to supporting the pharmaceutical industry's most complex small ...
read more
GXP-Storage is expanding its UK operations with a third restricted-access facility in Raunds, Northamptonshire, adding more than 95,000 cubic feet of GxP-compliant, environmentally controlled storage capacity.
read more
Woodstock Sterile Solutions has appointed pharmaceutical industry veteran Wilfredo Ortiz as General Manager.
read more
Scinai Immunotherapeutics announced that its wholly owned subsidiary, Scinai Biopharma Services, has appointed Mr. Eran Kuratz as Head of Supply Chain and Business Process Administration.
read more
Thursday, August 06, 2026
Altasciences has completed an expansion of the research and development laboratory at its drug product formulation and manufacturing facility in Harleysville, Pennsylvania, adding about 768 square feet of new lab space.
read more
Wednesday, August 05, 2026
Altruist Biologics has completed the first commercial process performance qualification campaign for its 20,000L stainless steel bioreactors at its Hangzhou site, marking successful commercial-scale completion of three consecutive batches.
read more
Wednesday, August 05, 2026
Porton Advanced Solutions has secured a Drug Manufacturing License (Class C) from China’s National Medical Products Administration, a milestone that allows the company to undertake commercial contract manufacturing for cell and gene therapy products.
read more
Wednesday, August 05, 2026
Clinilabs has appointed Bob Dagher, M.D., as chief medical officer and Waqar Ahmed Siddiqui, M.D., as principal investigator at its Eatontown, New Jersey clinical research unit.
read more
Piramal Pharma Solutions has expanded its peptide API facility in Turbhe, India, with a new spray drying suite designed to support challenging formulations for peptides, HPAPIs and other biomolecules.
read more
Resilience announced it has expanded its strategic partnership with Eli Lilly and Company to increase U.S. production of critical medicines featuring new pharmaceutical manufacturing investments in Ohio.
read more
Genezen and the Raiden Science Foundation have announced a manufacturing partnership for an AAV9 gene replacement therapy for UBA5 disorder, moving the program closer to a first-in-human clinical trial.
read more
Codis has completed its acquisition of Catalent’s Nottingham, UK facility, a move that expands the company’s integrated spray dry offering in Europe and adds oral solid dose development and small-scale commercial manufacturing capabilities.
read more